News | July 22, 2009

Roche Cardiac 200 Offers Rapid Diagnostics at the Point of Care

July 22, 2009 – Roche Diagnostics today introduced the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.

The Roche Cardiac 200 is a lateral flow immunoassay testing system designed to provide quantitative cardiac marker test results on whole blood samples with a turnaround time of 10 to 19 minutes, to help meet best practice guidelines for emergency department settings.

Patients who present to the emergency department (ED) with symptoms of a cardiovascular event are typically tested for a series of "cardiac markers," or chemicals that the body releases as an indication of recent heart damage or potential cardiovascular problems. Often the ED physicians treating these patients cannot afford to wait for traditional testing methods, which can take longer than 60 minutes.

The Roche Cardiac 200 can process up to 36 tests per hour and offers a full cardiac marker menu that includes NT-proBNP, Troponin I (TnI), CKMB and Myoglobin. The instrument uses a unique internal corrected fluorescence measurement technology to deliver accuracy and reliability that are consistent with the performance expectations of laboratory systems as defined by the National Academy of Clinical Biochemistry. The company also said studies have shown that Roche Cardiac 200 diagnostic results for NT-proBNP and Troponin I are essentially equivalent to core lab results.

The Roche Cardiac 200 offers an easy-to-read touch screen and flexible modular configurations to enable labs to address specific workflow needs. It also uses a proprietary internal standard that eliminates the need for routine recalibration.

For more information:

Related Content

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing | September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing | May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing | April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing | April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing | April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing | March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing | January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing | July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
News | Blood Testing | March 22, 2016
March 22, 2016 — Critical Diagnostics announced that it entered into a license agreement for the exclusive worldwide
Overlay Init